| |
|
|

CURRICULUM VITAE
|
Current Position: [photo
and summary]
EDUCATION:
1981-87
M. D. Shanghai Medical
University, School of Medicine, Shanghai, China
1987-89
Clinical Pharmacology
Residency
Institute of
Clinical Pharmacology
Shanghai Medical
University, Shanghai, China
1990-94
Ph.D.
The Graduate
School of Biomedical Sciences
University of
Texas Medical Branch at Galveston, Texas
1994
Postdoctoral
Fellowship, Sealy Center for Molecular Biology
University of
Texas Medical Branch at Galveston, Texas
1/95-12/98
Pathology Residency
(combined anatomic and clinical pathology program)
The UMDNJ-Robert
Wood Johnson Medical School, New Brunswick, NJ
|
PROFESSIONAL
EXPERIENCES AND CERTIFICATIONS:
3/00-present
Associate pathologist
at Lexington Medical Center, West Columbia, SC (with Pathology
Associates of Lexington, P.A.)
3/99-2/00
Pathology Service,
Independent Contractor for Pathology Associates of Lexington,
P.A., at Lexington Medical Center, West Columbia, SC
1994 Certified
by ECFMG (#0-469-802-3)
1998 American
Board of Pathology; certified in Anatomic Pathology/Clinical
Pathology
1998 Licensed
in the state of New Jersey (#MA067287)
1999 Licensed
in the state of South Carolina (#20697)
HONORS:
1996 First place,
Resident in Service Slides Contest
Awarded by the
Joint Pathology Residency Program of the UMDNJ-Robert Wood Johnson
Medical School and the St. Peter's Medical Center, New Brunswick,
NJ.
1994 Rose and
Harry Walker Research Award
Awarded by the
Graduate School of the University of Texas Medical Branch at
Galveston, Texas
1992 The James
E. Beall II Memorial Award for Academic Excellence.
Awarded by
the Graduate School of the University of Texas Medical Branch at
Galveston, Texas
1987 Cum Laude
Graduate, Shanghai Medical University, School of Medicine, Shanghai,
China |
RESEARCH
ACTIVITIES:
1987 Fructose
diphosphate on platelet aggregation and calcium regulation
1987-89 Genetic
polymorphism of debrisoquine hydroxylation and sulfadimidine
acetylation
1990 Smoking
related free radical damage in proteins
1991 Bromobenzene
toxicity
1991-94 Steroid
receptor molecular and cell biology
1994 Regulation
of PTH-like peptide gene expression in breast cancer cells
1996 Mannose
6-phosphate in breast cancer and its clinical correlations
1997 Collagen
XV and XVIII expression in human tissues
1998 PCR analysis
of DNA from paraffin embedded tissues
TEACHING
EXPERIENCE:
1998 Pathology
Course for physician assistants at Robert Wood Johnson Medical
School, New Brunswick, NJ
1997 Pathology
Case Based Study for medical students at Robert Wood Johnson
Medical School, New Brunswick, NJ
1988-89 Pharmacology
Laboratory Course and Medical Pharmacology for medical students
at Shanghai Medical University
ACADEMIC & PROFESSIONAL
MEMBERSHIPS:
Fellow, College
of American Pathologists
Fellow, American Society of Clinical Pathologists
Member, South Carolina Society of Pathologists
Member, South
Carolina Medical Association
Member, Lexington
Medical Association
Member, American
Medical Association
|
SELECTED
PUBLICATIONS:
X. K. Xu (2004)
Right ventricular fatty replacement as the possible missing link
between fatty liver and sudden death. Med Hypothese
Res 1: 253-260.
Amenta, P.S.,
Briggs, K., Xu, X., Gamboa, E., Jukkola, A.F., Li, D.,
and Myers, J.C. (2000) Type XV collagen in human colonic adenocarcinomas
has a different distribution than other basement membrane zone
proteins. Human Pathology 31(3): 359-66
Xu, X.,
and Thomas, M.L. (1995) Biphasic actions of estrogen on colon
cancer cell growth: Possible mediation by high- and low- affinity
estrogen binding sites. Endocrine 3:661-665.
Zhang, R.W.,
Supowit, S.C., Xu, X., Li, H., Christensen, M.D., Lozano,
R., and Simmons, D.J. (1995) Expression of selected osteogenic
markers in the fibroblast-like cells of rat marrow stroma. Calcified
Tissue International 56: 283-291.
Xu, X.,
and Thomas, M.L. (1994) Estrogen receptor-mediated direct stimulation
of colon cancer cell growth in vitro. Molecular and
Cellular Endocrinology 132: 426-430.
Thomas, M.L., Xu,
X., Norfleet, A.M., and Watson, C.S. (1993) The presence
of functional estrogen receptors in intestinal epithelial cells. Endocrinology 132:
426-430.
Wang, H., Xu,
X., Jiang, W., Zhu, J., Guo, Y., Chan, K., and Arnold,
K., (1990) An HPLC assay of debrisoquine and 4-hydroxydebrisoquine. Acta
Acadamiae Medicinae Shanghai 17: 269-274.
Xu, X.,
and Jiang, W. (1990) Debrisoquine hydroxylation and sulfamethazine
acetylation in a Chinese population. Acta Pharmacologica Sinica
[English Edition] 11:385.
Xu, X.,
Jiang, W., and Guo, Y. (1990) High-performance liquid chromatographic
determination of sulfadimidine and N-acetylsulfadimidine in blood.
Chinese Pharmacological Bulletin 6:190-200.
Xu, X.,
and Jiang, W. (1989) Debrisoquine hydroxylation in a Chinese
population. Chinese Journal of Physiological Sciences [English
Edition] 5:361-366. |
INVITED
PRESENTATIONS AT PROFESSIONAL MEETINGS:
Jiang, W.D.,
and Xu, X. Debrisoquine hydroxylation in a Chinese population.
IV World Conference on Clinical Pharmacology and Therapeutics.
1989, Mannheim, Heidelberg.
Xu, X.,
Norfleet, A.M., Watson, C.S., and Thomas, M.L., Evidence for
the presence of estrogen receptors in rat intestinal epithelium.
Proceedings of the 74th Annual Meeting of American
Endocrine Society. 1992, San Antonio.
Xu, X.,
and Thomas, M.L., High- and low-affinity estrogen binding and
estrogen effects on the growth of a colon cancer cell line. Proceedings
of the IX International Congress of Hormonal Steroids. 1994,
Dallas.
Xu, X.,
Stewart, L.V., and Thomas, M.L., Estrogen receptor-mediated direct
stimulation of colon cancer cell growth in vitro. Proceedings
of the IX International Congress of Hormonal Steroids. 1994,
Dallas.
10/05 |
|
|